SEBI Reg. Investment Advisor

Download App

MoneyWorks4Me

Sotac Pharmaceutical - Quaterly Results

13 Aug 2024 Evaluate
The Sales for the quarter ended June 2024 of Rs. 130.13 million declined by -31.18% from Rs. 189.10 millions.Net profit for the quarter ended June 2024 increases to Rs. 12.54  millions from Rs. 12.04 millions.Operating profit for the quarter ended June 2024 rose to 25.34 millions as compared to 24.90 millions of corresponding quarter ended June 2023.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202406 202306 % Var 202406 202306 % Var 202403 202303 % Var
Sales 130.13 189.10 -31.18 130.13 189.10 -31.18 671.05 579.83 15.73
Other Income 4.30 2.32 85.34 4.30 2.32 85.34 13.19 2.43 442.80
PBIDT 25.34 24.90 1.77 25.34 24.90 1.77 115.13 84.52 36.22
Interest 2.57 3.42 -24.85 2.57 3.42 -24.85 10.13 8.61 17.65
PBDT 22.77 21.48 6.01 22.77 21.48 6.01 102.66 75.91 35.24
Depreciation 6.04 4.63 30.45 6.04 4.63 30.45 25.11 16.25 54.52
PBT 16.73 16.85 -0.71 16.73 16.85 -0.71 77.55 59.66 29.99
TAX 4.19 4.81 -12.89 4.19 4.81 -12.89 20.06 14.69 36.56
Deferred Tax -0.16 0.25 -164.00 -0.16 0.25 -164.00 -0.82 -2.15 -61.86
PAT 12.54 12.04 4.15 12.54 12.04 4.15 57.49 44.97 27.84
Equity 110.50 110.50 0.00 110.50 110.50 0.00 110.50 80.50 37.27
PBIDTM(%) 19.47 13.17 47.88 19.47 13.17 47.88 17.16 14.58 17.70
Peers
Company Name CMP
Sun Pharma Inds. 1668.00
Dr. Reddys Lab 1232.25
Cipla 1228.90
Zydus Lifesciences 936.35
Lupin 2328.60
View more..

About MoneyWorks4Me

MoneyWorks4Me is a SEBI-registered Investment Adviser (IA) dedicated to helping investors build long-term wealth through transparent, research-driven, conflict-free guidance. Founded in 2008, we started our journey as a Research Analyst (RA), providing deep fundamental analysis, intrinsic value insights, and long-term investing frameworks for Indian equities. In 2017, we transitioned to a full-fledged SEBI-registered Investment Adviser, strengthening our commitment to acting as a fiduciary—always putting the investor’s interest first.

Our Vision

To become India’s most trusted, research-powered fiduciary advisory platform—where every investor, regardless of experience, can make calm, confident, and well-reasoned investment decisions.

What Makes MoneyWorks4Me Different

Our Approach: Ensuring compounding work its magic on client portfolio.

MoneyWorks4Me ensures this through:

×